BioCryst Pharmaceuticals and Idera Pharmaceuticals Reschedule Meetings to Vote on Proposed Merger

RESEARCH TRIANGLE PARK, N.C. & EXTON, Pa.--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst”) and Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) (“Idera”) today jointly announced that they have each rescheduled their respective Special Meetings of Stockholders (each, a “Special Meeting”) to vote on the proposed merger of BioCryst and Idera to July 10, 2018 at 10:00 AM ET.